TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

Summary

A randomized, controlled, open-label multicenter trial to assess the safety and efficacy of 3 oxaliplatin-fluoropyrimidine containing regimens (mFOLFOX6; bFOL; XELOX) + Bevacizumab (TREE1 and TREE2) as first line therapy of advanced metastatic colorectal cancer.

Timeline

Start

2002-11

Primary completion

—

Completion

2005-06

Drugs

Indications